PSNL
Personalis Inc
NASDAQ: PSNL · HEALTHCARE · DIAGNOSTICS & RESEARCH
$5.04
-8.36% today
Updated 2026-04-29
Market cap
$575.73M
P/E ratio
—
P/S ratio
8.27x
EPS (TTM)
$-0.91
Dividend yield
—
52W range
$4 – $12
Volume
1.6M
WallStSmart proprietary scores
24
out of 100
Grade: F
Strong Sell
Investment rating
4.0
Growth
C5.0
Quality
C+2.0
Profitability
F4.0
Valuation
C—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$11.29
+124.01%
12-Month target
—
—
Intrinsic (DCF)
$5.88
Margin of safety
-51.36%
1 Strong Buy5 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at -116.70%
- Negative free cash flow $-22.32M
- 51.36% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $65.05M | $73.48M | $84.61M | $69.65M | $69.65M |
| Net income | $-113.31M | $-108.30M | $-81.28M | $-81.27M | $-23.81M |
| EPS | — | — | — | — | $-0.91 |
| Free cash flow | $-120.13M | $-67.17M | $-46.75M | $-79.45M | $-22.32M |
| Profit margin | -174.20% | -147.38% | -96.06% | -116.69% | -116.70% |
Peer comparison
Smart narrative
Personalis Inc trades at $5.04. Our Smart Value Score of 24/100 indicates the stock is weak. TTM revenue stands at $69.65M. with profit margins at -116.70%. Our DCF model estimates intrinsic value at $5.88.
Frequently asked questions
What is Personalis Inc's stock price?
Personalis Inc (PSNL) trades at $5.04.
Is Personalis Inc overvalued?
Smart Value Score 24/100 (Grade F, Strong Sell). DCF value $5.88.
What is the price target of Personalis Inc (PSNL)?
The analyst target price is $11.29, representing +124.0% upside from the current price of $5.04.
What is the intrinsic value of Personalis Inc (PSNL)?
Based on our DCF model, intrinsic value is $5.88, a -51.4% margin of safety versus $5.04.
What is Personalis Inc's revenue?
TTM revenue is $69.65M.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio8.27x
ROE-35.00%
Beta2.21
50D MA$7.26
200D MA$7.52
Shares out0.10B
Float0.07B
Short ratio—
Avg volume1.6M
Performance
1 week-6.78%
1 month-13.66%
3 months-44.83%
YTD-30.90%
1 year—
3 years—
5 years—